Navigation Links
Royalty Pharma Files Judicial Review Proceedings
Date:6/11/2013

NEW YORK, June 11, 2013 /PRNewswire/ -- Royalty Pharma today announces that it has reluctantly filed judicial review proceedings related to the decision of the Irish Takeover Panel requiring it to lapse its Further Increased Offer in the event that the ELND005 Transaction and / or the Share Repurchase Program are approved at the Elan (NYSE: ELN) EGM on 17 June 2013.

Royalty Pharma had requested permission from the Irish Takeover Panel to the effect that it would not be obliged to lapse (withdraw) the Offer in the event that the ELND005 Transaction and / or the Share Repurchase Program were approved at the Elan EGM. On 6 June 2013, the Irish Takeover Panel ruled that Royalty Pharma will be required to lapse the Further Increased Offer in the event that either the ELND005 Transaction and / or the Share Repurchase Program are approved at the Elan EGM.

If Elan shareholders approve either the ELND005 Transaction and / or the Share Repurchase Program, Royalty Pharma is concerned that the Irish Takeover Panel's decision will deprive Elan shareholders of the opportunity to consider Royalty Pharma's Further Increased Offer.

IN ORDER TO ENSURE THAT ELAN SHAREHOLDERS HAVE AN OPPORTUNITY TO CONSIDER ROYALTY PHARMA'S FURTHER INCREASED OFFER, ELAN SHAREHOLDERS ARE URGED TO VOTE "AGAINST" ALL FOUR RESOLUTIONS  PROPOSED BY ELAN AT ITS UPCOMING EGM ON 17 JUNE 2013, INCLUDING THE ELND005 TRANSACTION AND THE SHARE REPURCHASE PROGRAM.  

Royalty Pharma will withdraw these judicial review proceedings if Elan shareholders vote down all four resolutions proposed by Elan at its upcoming EGM on 17 June 2013.

Capitalized terms used but not defined in this announcement have the meaning given to them in Royalty Pharma's Further Revised Offer Document.

J.P. Morgan, together with its affiliate J.P. Morgan Cazenove, BofA Merril
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan
2. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
3. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
4. Royalty Pharma Acceptances Announcement
5. Royalty Pharma Responds To Elans Tysabri Valuation
6. Royalty Pharma Response To Elans "Categorical View On Value"
7. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
8. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
9. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
10. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
11. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
(Date:12/24/2014)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Jennifer Hagerman , Pharm.D., AE-C, senior director of ... the president of the Michigan Pharmacists Association on Jan. ... Feb. 28, 2015, at the MPA Annual Convention and ... in Detroit, Michigan . Hagerman will ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
... C. Lechleiter, Ph.D., chairman, president and chief executive officer ... ), today urged that biopharmaceuticals be included in transatlantic ... Council on Germany,s conference on "The Transatlantic Partnership in ... German State Secretary in the Federal Finance Ministry Jorg ...
... The U.S. Food and Drug Administration (FDA) has approved ... Vaccine, Adsorbed (Tdap)] for use in adults 65 years ... tetanus, diphtheria and pertussis (whooping cough). This approval makes ... this age group.  With this expanded indication, BOOSTRIX is ...
Cached Medicine Technology:Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 3GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 4
(Date:12/25/2014)... December 25, 2014 BambooFlooringChina.com sells many ... quality bamboo flooring. Today, the company announces big ... many styles and colors. , BambooFlooringChina.com is the world’s ... the promotion is valid until Jan. 20, 2015. , ... and woven with a natural thread. All the bamboo ...
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... can receive effective, less expensive care from a clinic that ... team of dedicated health care professionals, a new study shows. ... need either hospitalization or a trip to the emergency room ... at the University of Texas in Houston versus usual care, ...
(Date:12/25/2014)... (HealthDay News) -- Overeating is common during the holidays, but ... an expert says. "Don,t arrive at a party hungry. ... know you,ll be attending a party, but deprivation leads to ... at Northern Westchester Hospital in Mount Kisco, N.Y., said in ... during the day and even to have a snack before ...
(Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
Breaking Medicine News(10 mins):Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3
... find out why people can,t let go of what is theirs ... thrown a yard sale knows, it can be hard to part ... attempt to grasp this all too human -- and sometimes irrational ... having a tenacious grip on the stuff you own has little ...
... Pharmaceuticals, Inc.,announced today that the U.S. Food and ... Company,s Abbreviated New Drug Application,(ANDA) for Ramipril capsules, ... mg. Commercial,shipments of the product have commenced., ... of King,Pharmaceutical,s Altace(R) capsules, indicated for the treatment ...
... Ind., June 11 Conseco, Inc. (NYSE:,CNO) announced ... vice,president and general counsel of Conseco. Zimpfer, who ... report to CEO Jim Prieur., (Photo: ... in the insurance industry in litigation,legal counsel, compliance ...
... June 11, 2008 A new report entitled Business ... the London School of Hygiene & Tropical Medicine (LSHTM), ... the level of advice given to businesses to prepare ... and disruption to business during a flu pandemic is ...
... It appears that disrupted rest and activity rhythms are ... new University of Minnesota research. , A group of about ... activity biological rhythms via a wrist device called an actigraph. ... rest and activity, as well as the robustness of the ...
... ... and Easy-to-Use, ST. LOUIS, June 11 Millions ... and they want to provide them,with the best care possible for a ... resulted in,dogs and cats living longer than ever before. Many medical advances ...
Cached Medicine News:Health News:Possession Is Nine-Tenths the Perceived Value 2Health News:Possession Is Nine-Tenths the Perceived Value 3Health News:Lupin Launches Ramipril Capsules 2Health News:Lupin Launches Ramipril Capsules 3Health News:European businesses not properly advised on how to prepare for flu pandemic 2Health News:Disturbed rest, activity linked to mortality in older men 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 4
For use with E5381 600 Circling Band (40 style)....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Used with Double Tantalum Clip (250 style) E5381 852. Overall length: 7.0 mm....
Medicine Products: